Trial Profile
Safety, Tolerability, Pharmacokinetic Profile and Ex-vivo Antitubercular Activity of PBTZ169 Formulated as Spray- Dried Dispersion Versus Native Crystal Powder: Single Ascending Doses, Randomized, Placebo- Controlled, Cross-over Phase Ia Trial in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2018
Price :
$35
*
At a glance
- Drugs Macozinone (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 12 Jul 2018 Status changed from recruiting to completed.
- 09 Feb 2018 New trial record